Compare ABEV & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABEV | KVUE |
|---|---|---|
| Founded | 1885 | 2022 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Specialty Chemicals |
| Sector | Consumer Staples | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.4B | 34.9B |
| IPO Year | 2012 | 2023 |
| Metric | ABEV | KVUE |
|---|---|---|
| Price | $2.81 | $17.53 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 11 |
| Target Price | $2.69 | ★ $19.73 |
| AVG Volume (30 Days) | 21.9M | ★ 22.7M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 6.80% | 4.72% |
| EPS Growth | N/A | ★ 40.74 |
| EPS | N/A | ★ 0.76 |
| Revenue | N/A | ★ $15,124,000,000.00 |
| Revenue This Year | $7.85 | $4.82 |
| Revenue Next Year | $5.23 | $2.61 |
| P/E Ratio | ★ $16.99 | $23.12 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.10 | $14.02 |
| 52 Week High | $3.24 | $25.17 |
| Indicator | ABEV | KVUE |
|---|---|---|
| Relative Strength Index (RSI) | 42.74 | 41.25 |
| Support Level | $2.70 | $17.13 |
| Resistance Level | $3.24 | $17.52 |
| Average True Range (ATR) | 0.07 | 0.26 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 27.03 | 20.99 |
Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving AB InBev a controlling interest of 62%.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.